Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde (Mar 2022)

Clinical pharmacist interventions in a hospital emergency

  • Nara S. SANTOS,
  • Diana S. LOPES,
  • Tamiles B. SANTANA,
  • Ana S. MASCARENHAS,
  • Adriano M. MOREIRA-REIS,
  • Gisele S. LEMOS

DOI
https://doi.org/10.30968/rbfhss.2022.131.0731
Journal volume & issue
Vol. 13, no. 1

Abstract

Read online

Objective: To identify the types of interventions performed by clinical pharmacists in an intensive care unit and in the emergency of a hospital in the interior of Bahia. Methods: Cross-sectional study, carried out in a regional reference hospital for 27 cities, from May to August 2019. A form designed for the research was used, considering the interventions registered in the patient’s medical record. Pearson’s chi-square test was used to compare the proportions of categorical variables. Results: 814 interventions were performed in 102 patients, with a median of 14 and an interquartile range of 23. Of the most frequent interventions, 36.2% were related to drug interactions, with 99.2% being monitored (p<0.001); 10.8% dosage adjustment in renal failure interventions with 72.7% not accepted (p<0.001); 8.5% for dose interval with 73.9% not accepted (p<0.001) and 6.1% of interventions that involved orientation (nursing guidelines) with 73.9% that were monitored (p<0.001). Of the total interventions, 63.8% took place in the intensive care unit, 52.7% in male patients and 66.7% in people aged ≥ 60 years. Regarding the use of alerts, 53.4% of the interventions that were accepted had alerts (p<0.001). 46.7% were directed to the medical team; 44.9% for more than one professional; 5.8% for nurses; and 2.6% for nursing technicians. The drugs related to the interventions performed were grouped according to the ATC classification, as follows: 20.5% in group J-Antiinfectives for systemic use, 18.8% in group A-Alimentary tract and metabolism; 12.4% of the C-Cardiovascular sistem device group. Conclusion: The number of interventions performed, as well as the population and sectors assisted demonstrate the importance of the clinical pharmacist inserted in the multidisciplinary team in the care of critically ill patients.